tradingkey.logo

AxoGen Inc

AXGN
35.428USD
+0.408+1.17%
Horarios del mercado ETCotizaciones retrasadas 15 min
1.63BCap. mercado
PérdidaP/E TTM

Más Datos de AxoGen Inc Compañía

Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.

Información de AxoGen Inc

Símbolo de cotizaciónAXGN
Nombre de la empresaAxoGen Inc
Fecha de salida a bolsaDec 17, 1986
Director ejecutivoDale (Michael Donald)
Número de empleados451
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 17
Dirección13631 Progress Blvd.
CiudadALACHUA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal32615
Teléfono13864626817
Sitio Webhttps://www.axogeninc.com/
Símbolo de cotizaciónAXGN
Fecha de salida a bolsaDec 17, 1986
Director ejecutivoDale (Michael Donald)

Ejecutivos de AxoGen Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Lindsey Hartley
Ms. Lindsey Hartley
Chief Financial Officer
Chief Financial Officer
31.38K
+10613.00%
Mr. Jens Schroeder Kemp
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Chief Marketing Officer
27.03K
+14344.00%
Mr. Erick Wayne Devinney
Mr. Erick Wayne Devinney
Chief Innovation Officer
Chief Innovation Officer
--
--
Ms. Amy A. Mcbride-Wendell
Ms. Amy A. Mcbride-Wendell
Lead Independent Director
Lead Independent Director
--
--
Mr. Alan M. Levine
Mr. Alan M. Levine
Independent Director
Independent Director
--
--
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
--
-21399.00%
Mr. John H. Johnson
Mr. John H. Johnson
Independent Director
Independent Director
--
--
Mr. William P. (Bill) Burke
Mr. William P. (Bill) Burke
Independent Director
Independent Director
--
--
Dr. Joseph (Adrian) Tyndall, M.D.
Dr. Joseph (Adrian) Tyndall, M.D.
Independent Director
Independent Director
--
--
Mr. Marc A. Began
Mr. Marc A. Began
Executive Vice President, Chief Compliance Officer, General Counsel
Executive Vice President, Chief Compliance Officer, General Counsel
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Lindsey Hartley
Ms. Lindsey Hartley
Chief Financial Officer
Chief Financial Officer
31.38K
+10613.00%
Mr. Jens Schroeder Kemp
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Chief Marketing Officer
27.03K
+14344.00%
Mr. Erick Wayne Devinney
Mr. Erick Wayne Devinney
Chief Innovation Officer
Chief Innovation Officer
--
--
Ms. Amy A. Mcbride-Wendell
Ms. Amy A. Mcbride-Wendell
Lead Independent Director
Lead Independent Director
--
--
Mr. Alan M. Levine
Mr. Alan M. Levine
Independent Director
Independent Director
--
--
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
--
-21399.00%

Desglose de ingresos

FY2023
FY2022
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
United States
159.01M
0.00%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: vie., 2 de ene
Actualizado: vie., 2 de ene
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
First Light Asset Management, LLC
11.58%
BlackRock Institutional Trust Company, N.A.
6.34%
The Vanguard Group, Inc.
5.70%
Morgan Stanley & Co. LLC
4.56%
ArrowMark Colorado Holdings, LLC
3.91%
Otro
67.90%
Accionistas
Accionistas
Proporción
First Light Asset Management, LLC
11.58%
BlackRock Institutional Trust Company, N.A.
6.34%
The Vanguard Group, Inc.
5.70%
Morgan Stanley & Co. LLC
4.56%
ArrowMark Colorado Holdings, LLC
3.91%
Otro
67.90%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
37.23%
Investment Advisor
27.86%
Hedge Fund
13.23%
Research Firm
5.95%
Individual Investor
2.50%
Family Office
1.62%
Bank and Trust
0.41%
Pension Fund
0.30%
Sovereign Wealth Fund
0.12%
Otro
10.77%

Participación institucional

Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
342
42.08M
97.83%
+8.74K
2025Q3
350
42.06M
101.71%
+627.35K
2025Q2
344
41.40M
98.61%
+1.26M
2025Q1
339
40.15M
93.21%
-2.27M
2024Q4
327
37.35M
99.16%
-1.08M
2024Q3
305
37.98M
92.55%
+3.00M
2024Q2
285
37.71M
96.69%
+1.44M
2024Q1
290
36.54M
95.40%
-4.68M
2023Q4
299
34.97M
92.73%
+437.14K
2023Q3
304
34.60M
92.75%
-2.09M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
First Light Asset Management, LLC
5.81M
12.59%
+1.28M
+28.18%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
3.18M
6.89%
+76.53K
+2.47%
Sep 30, 2025
The Vanguard Group, Inc.
2.67M
5.79%
-51.00K
-1.87%
Sep 30, 2025
Morgan Stanley & Co. LLC
2.29M
4.96%
+352.54K
+18.22%
Sep 30, 2025
ArrowMark Colorado Holdings, LLC
1.96M
4.25%
+332.50K
+20.45%
Sep 30, 2025
Soleus Capital Management, L.P.
1.73M
3.74%
+267.16K
+18.31%
Sep 30, 2025
Wasatch Global Investors Inc
1.64M
3.55%
+205.57K
+14.34%
Sep 30, 2025
Assenagon Asset Management S.A.
1.29M
2.79%
+265.95K
+25.99%
Sep 30, 2025
Balyasny Asset Management LP
1.38M
2.99%
-551.52K
-28.56%
Sep 30, 2025
Armistice Capital LLC
1.20M
2.6%
+88.68K
+7.98%
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
ROBO Global Healthcare Technology & Innovation ETF
3.51%
State Street SPDR S&P Health Care Equipment ETF
2.3%
iShares Neuroscience and Healthcare ETF
2.11%
Invesco Dorsey Wright Healthcare Momentum ETF
0.97%
Invesco NASDAQ Future Gen 200 ETF
0.74%
JPMorgan Fundamental Data Science Small Core ETF
0.21%
iShares Micro-Cap ETF
0.19%
Fidelity Enhanced Small Cap ETF
0.18%
Principal U.S. Small-Cap ETF
0.15%
Franklin US Small Cap Multifactor Index ETF
0.14%
Ver más
ROBO Global Healthcare Technology & Innovation ETF
Proporción3.51%
State Street SPDR S&P Health Care Equipment ETF
Proporción2.3%
iShares Neuroscience and Healthcare ETF
Proporción2.11%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporción0.97%
Invesco NASDAQ Future Gen 200 ETF
Proporción0.74%
JPMorgan Fundamental Data Science Small Core ETF
Proporción0.21%
iShares Micro-Cap ETF
Proporción0.19%
Fidelity Enhanced Small Cap ETF
Proporción0.18%
Principal U.S. Small-Cap ETF
Proporción0.15%
Franklin US Small Cap Multifactor Index ETF
Proporción0.14%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI